225Ac-anti-CCR8 treatment resulted in modest expansion of M2 macrophages (CT26: p=0.2460, MC38: p=0.0675), however, this cells population was low and represented <5% of total Mφ numbers within the tumor. Here, CCR8 is linked to neoplasm.